Citations 12
A phase 2 study of a nivolumab (nivo)-containing regimen in patients (pts) with newly diagnosed classical Hodgkin lymphoma (cHL): Study 205 Cohort D.
Armand, Philippe , Ramchandren, Radhakrishnan , Timmerman, John M. , Sumbul, Anne, Ruisi, Mary, Kato, Kazunobu, Ansell, Stephen M. , Shipp, Margaret Ann , Kuruvilla, John , Collins, Graham P.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS7573-TPS7573
NIVOLUMAB FOR RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA AFTER AUTOLOGOUS TRANSPLANT: FULL RESULTS AFTER EXTENDED FOLLOW‐UP OF THE PHASE 2 CHECKMATE 205 TRIAL
Fanale, Michelle A. , Engert, Andreas , Younes, Anas , Armand, Philippe , Ansell, Stephen M. , Timmerman, John M. , Ramchandren, Radhakrishnan , Cohen, Jonathon B. , Kato, Kazunobu, Sumbul, Anne, Zinzani, Pier Luigi , Collins, Graham P. , Boer, Jan Paul de , Kuruvilla, John , Savage, Kerry J. , Trněný, Marek , Rodig, Scott J , Shipp, Margaret Ann , Farsaci, Benedetto , Santoro, Armando
Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 135-136